Medtronic & DaVita Launch Mozarc Medical, Will Introduce Solutions For Consumers With Kidney Failure

Medtronic plc and DaVita Inc. launched Mozarc Medical—an independent new company committed to reshaping kidney health and driving consumer-centered technology solutions. Mozarc Medical is co-owned by Medtronic and DaVita, each with equal equity stakes. The company will seek to develop innovative kidney health technologies that improve the overall consumer experience and increase access to care globally.

Mozarc Medical’s intellectual property includes the former Medtronic Renal Care Solutions (RCS) business. Through the first three quarters of Medtronic's fiscal year 2023, the RCS business had revenue of $64 million, $63 million, and $70 million, respectively.

Medtronic plc . . .